首页> 美国卫生研究院文献>Proceedings of the National Academy of Sciences of the United States of America >Relationship between O6-alkylguanine-DNA alkyltransferase activity and N-methyl-N-nitro-N-nitrosoguanidine-induced mutation transformation and cytotoxicity in C3H/10T1/2 cells expressing exogenous alkyltransferase genes.
【2h】

Relationship between O6-alkylguanine-DNA alkyltransferase activity and N-methyl-N-nitro-N-nitrosoguanidine-induced mutation transformation and cytotoxicity in C3H/10T1/2 cells expressing exogenous alkyltransferase genes.

机译:在表达外源烷基转移酶基因的C3H / 10T1 / 2细胞中O6-烷基鸟嘌呤-DNA烷基转移酶活性与N-甲基-N-硝基-N-亚硝基胍诱导的突变转化和细胞毒性之间的关系。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

While a great deal of evidence has directly implicated the importance of O6-alkylation of guanine in the mutagenicity of alkylating agents, evidence demonstrating the oncogenic potential of this lesion has been largely indirect. We have combined a well-studied in vitro neoplastic transformation system (using C3H/10T1/2 mouse cells) with a proven method of gene transfection for expressing the bacterial O6-alkylguanine-DNA alkyltransferase (AT; EC 2.1.1.63) repair genes ada and ogt to generate subclones which possess augmented repair capability toward specific DNA lesions. The products of these genes specifically and differentially repair O6-methylguanine (O6-MeGua), O4-methylthymine (O4-MeThy), and methylphosphotriesters. We show that the level of expression of either the ada or the ogt AT gene in C3H/10T1/2 cells directly correlates with protection against mutation to ouabain resistance by N-methyl-N'-nitro-N-nitrosoguanidine (MNNG). Subclones expressing 70 fmol of AT per 10(6) cells exhibited a mutation frequency approximately 1/40th of that of clones expressing 15 fmol of AT per 10(6) cells when treated with MNNG at 0.4 micrograms/ml. Protection against mutagenesis by MNNG at 0.8 micrograms/ml, however, did not exceed 12-fold even in subclones expressing greater than 100 fmol of AT per 10(6) cells. As an MNNG dose of 0.6 micrograms/ml was sufficient to saturate more than 95% of the AT activity in any of the clones, the residual mutation frequency may have been caused by unrepaired O6MeGua lesions. In contrast to mutagenesis, protection against neoplastic transformation in vitro, in cells expressing high levels of AT, was most pronounced in cells treated with the highest dose of MNNG used (1.2 micrograms/ml). Low levels of transformation caused by MNNG at 0.4 and 0.8 micrograms/ml were not consistently inhibited in those clones. These data suggest that O6-MeGua formation is of major but not unique significance in the neoplastic transformation of C3H/10T1/2 cells by MNNG.
机译:尽管大量证据直接表明鸟嘌呤的O6-烷基化在烷基化剂的致突变性中具有重要意义,但证明该病灶潜在致癌性的证据大部分是间接的。我们已经将经过充分研究的体外肿瘤转化系统(使用C3H / 10T1 / 2小鼠细胞)与经过验证的基因转染方法相结合,以表达细菌O6-烷基鸟嘌呤-DNA烷基转移酶(AT; EC 2.1.1.63)修复基因ada并产生对特定DNA损伤具有增强的修复能力的亚克隆。这些基因的产物可以特异性和差异性地修复O6-甲基鸟嘌呤(O6-MeGua),O4-甲基胸腺嘧啶(O4-MeThy)和甲基磷酸三酯。我们表明,ada或ogt AT基因在C3H / 10T1 / 2细胞中的表达水平与N-甲基-N'-硝基-N-亚硝基胍(MNNG)对哇巴因抗性突变的保护作用直接相关。当以0.4微克/毫升的MNNG处理时,每10(6)个细胞表达70 fmol AT的亚克隆的突变频率约为每10(6)细胞表达15 fmol AT的克隆的突变频率的十分之一/ 40。然而,即使在每10(6)个细胞中表达大于100 fmol AT的亚克隆中,MNNG对0.8微克/毫升的诱变保护也不会超过12倍。由于MNNG剂量为0.6微克/毫升足以使任何一个克隆中超过95%的AT活性饱和,因此残留突变频率可能是由未修复的O6MeGua损伤引起的。与诱变相反,在使用高剂量MNNG(1.2微克/毫升)处理的细胞中,表达高水平AT的细胞在体外对赘生性转化的保护最为明显。在这些克隆中,由MNNG导致的0.4和0.8微克/毫升的低水平转化未得到一致抑制。这些数据表明O6-MeGua的形成在MNNG对C3H / 10T1 / 2细胞的肿瘤转化中具有重要但并非唯一的意义。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号